Lynch et al. reported that low levels of plasma mitochondrial superoxide dismutase (MnSOD) within the first postnatal week are associated with increased risk of severe ROP in 35 preterm infants with GA < 29 weeks [47], suggesting potentially disturbed metabolic status in ROP infants. This evidence concerns the gene SOD2 and retinopathy of prematurity.